Osteoporosis in men: epidemiology and treatment with denosumab
Kristel M Sidlauskas, Emily E Sutton, Michael A Biddle Albany College of Pharmacy and Health Sciences-Vermont Campus, Colchester, VT, USA Abstract: Osteoporosis is a major public health care concern. Although often described as a disease affecting postmenopausal women, researchers and clinicians ha...
Guardado en:
Autores principales: | Sidlauskas KM, Sutton EE, Biddle MA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d7f2f454f05a4b7caa35297f994f5d0d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Treatment of primary osteoporosis in men
por: Giusti A, et al.
Publicado: (2014) -
Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatment
por: Claudia Gagnon, et al.
Publicado: (2008) -
Clinical utility of denosumab for treatment of bone loss in men and women
por: Adler R, et al.
Publicado: (2011) -
Management of bone metastases in refractory prostate cancer – role of denosumab
por: Paller CJ, et al.
Publicado: (2012) -
High bone turnover status as a risk factor in symptomatic hypocalcemia following denosumab treatment in a male patient with osteoporosis
por: Ishikawa K, et al.
Publicado: (2018)